Discounted Cash Flow (DCF) Analysis Levered

Bio-Path Holdings, Inc. (BPTH)

$4.12

+0.13 (+3.26%)
All numbers are in Millions, Currency in USD

Free Cash Flow

Year
A/P
2017
Actual
2018
Projected
2019
Projected
2020
Projected
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Revenue 0.04---------
Revenue (%)
Operating Cash Flow -7.96---------
Operating Cash Flow (%)
Capital Expenditure -0.54---------
Capital Expenditure (%)
Free Cash Flow -8.49---------

Weighted Average Cost Of Capital

Share price $ 4.12
Beta 1.745
Diluted Shares Outstanding 6.72
Cost of Debt
Tax Rate 0.00
After-tax Cost of Debt 5.00%
Risk-Free Rate
Market Risk Premium
Cost of Equity 11.048
Total Debt -
Total Equity 27.71
Total Capital 27.71
Debt Weighting 0.00
Equity Weighting 100.00
Wacc

Build Up Free Cash Flow

Year
A/P
2017
Actual
2018
Projected
2019
Projected
2020
Projected
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Revenue 0.04---------
Operating Cash Flow -7.96---------
Capital Expenditure -0.54---------
Free Cash Flow -8.49---------
WACC
PV LFCF ---------
SUM PV LFCF -

Terminal Value

Growth in perpetuity method:
Long-term growth rate
WACC (%) 11.05
Free cash flow (t + 1) -
Terminal Value -
Present Value of Terminal Value -

Intrinsic Value

Enterprise Value -
Net Debt -23.77
Equity Value -
Shares Outstanding 6.72
Equity Value Per Share -